|
Volume 271, Number 52,
Issue of December 27, 1996
pp. 33686-33692
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
NCp7 Activates HIV-1Lai RNA Dimerization by
Converting a Transient Loop-Loop Complex into a Stable Dimer*
(Received for publication, May 28, 1996, and in revised form, September 18, 1996)
Delphine
Muriaux
,
Hugues
De Rocquigny
§,
Bernard-Pierre
Roques
§ and
Jacques
Paoletti
¶
From Unité de Biochimie, URA 147 CNRS, 39 rue Camille
Desmoulins, Institut Gustave Roussy, 94805 Villejuif, France and
§ Département de Pharmacochimie Moléculaire et
Structurale, U266 INSERM, URA D1500 CNRS, Université
René Descartes, 4 avenue de l'Observatoire,
75006 Paris, France
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
Nucleocapsid protein 7 (NCp7), the human
immunodeficiency virus type 1 (HIV-1) nucleocapsid protein, was
shown to strongly potentiate the dimerization of the retroviral genomic
RNA. This process involves the interaction of two retroviral RNA
monomer subunits near their 5 -ends. A region located upstream from the splice donor site was recently identified as being responsible for the
formation of dimeric HIV-1 RNA. This region appeared to be confined
within a stem-loop structure, with an autocomplementary sequence in the
loop. In an in vitro study of spontaneous dimer formation,
we reported that the 77-402 RNA transcript forms two distinct dimers
differing in their thermostability: D37 and D55. We identified D37 as a
"kissing" complex structure, formed via a loop-loop interaction
between the two monomers, and D55 as a double stranded structure
involving all nucleotides of the stem-loop via canonical base pairing.
In this report, we have characterized the role of NCp7 in the
HIV-1Lai RNA dimerization process by using in
vitro dimerization assays with RNA transcripts of different lengths and dimer thermal dissociation. Our results show that the
nucleocapsid protein NCp7 activates RNA dimerization very likely
through interaction with the kissing complex and converts it into a
stable dimer. Furthermore, this NCp7-promoted conversion only occurs if
the 240-280 stem-loop structure is present in HIV-1Lai RNA
molecules and contains the autocomplementary
G257CGCGC262 sequence. This study suggests
that, under physiological conditions, an NCp7-mediated RNA
conformational change is involved in the maturation of the HIV-1 RNA
dimer.
INTRODUCTION
Retrovirus virions carry a diploid genome consisting of an RNA
complex formed by the association of two identical unspliced viral RNA
molecules (1). In mature virions, RNA molecules are tightly associated
with viral finger protein molecules, nucleocapsid proteins
(NCps)1 (2, 3). Retroviral NCp is generated
once the gag gene product, the structural Pr55gag protein,
has been processed by the viral protease (4) and is highly conserved
among all known retroviruses (5).
The HIV-1 NC protein (NCp7) is a small basic protein with two zinc
fingers of the
CX2CX4HX4C
form, flanked by regions rich in basic residues (5). Zinc fingers were
found to bind zinc with high affinity (6) through a tetracoordinated
complex involving the three cysteine residues and the histidine residue
(7). Nuclear magnetic resonance revealed the three-dimensional
structure of NCp7 (8, 9), and the zinc motifs were found to be in close
proximity due to the presence of the histidine residue and to the
conformation of the basic linker 29RAPRKKG35
(10, 11, 12). Point mutation of the conserved cysteine and histidine
residues resulted in a drastic reduction of genomic RNA packaging
(13, 14, 15). Moreover, mutation affecting NCp7 folding impairs the
co-assembly of Gag and Gag-pol precursors (10, 16) as well as the
protection of genomic RNA (11), and this results in a drastic decrease
in viral infectivity.
In vivo, NCp7 was shown to interact, at the 5 -end of
genomic RNA, with a sequence referred to as the sequence, located by directed mutagenesis between the primer binding site (PBS) and AUG
of the gag gene (14). Chimeric viruses containing a nonhomologous sequence and an NC-coding gene were noninfectious, suggesting a highly specific recognition process (17).
Previous works have reported in vitro studies on NCp7 and
have revealed its nucleic acid binding especially to the sequence (18) and annealing activities (2, 19, 20, 21, 22, 23, 24, 25, 26). NCp binds preferentially to
single-stranded nucleic acids with a high affinity for viral RNA (1).
Thus, NCp seems to play a key role in several steps of the viral life cycle. During reverse transcription, NCp stimulates tRNA primer annealing to the PBS at the 5 end of the viral RNA (19, 20, 21) and also
participates in the initial strand transfer event required for long
terminal repeat synthesis (22, 23, 24). NC protein has also been shown to
activate retroviral HIV-1 RNA dimerization in vitro (2, 21,
27), which results in the formation of the dimer linkage structure. The
dimer linkage structure, defined by electron microscopy, is an RNA-RNA
interaction site located in the sequence close to the 5 -ends of
viral RNA molecules (28, 29). The nature of the base-pairing
interactions of the dimer linkage structure has been studied by
analyzing spontaneous RNA transcript dimerization in vitro
(2, 27). Primary results were in favor of the hypothesis that HIV-1 RNA
dimerization involves purine-rich sequences, which should form
noncanonical base pairs (30, 31, 32). However, additional studies indicated
that such sequences are dispensable for RNA dimerization of HIV-2 (33), HIV-1 (34, 35), and Moloney murine leukemia virus (36). Another model
was thus proposed to explain the dimerization process of viral RNA.
HIV-1 (35, 37, 38, 39), Moloney murine leukemia virus (36), and avian
leukosis virus2 RNA transcripts, which
contain an autocomplementary sequence in a stem-loop structure, located
downstream from the PBS and upstream from the splice donor site, are
able to dimerize spontaneously in vitro. It has been
proposed that HIV-1 RNA dimer formation is initiated by the annealing
of these autocomplementary sequences via a loop-loop interaction
between the two RNA molecules, resulting in the formation of a
"kissing" complex at 37 °C (39). This intermediary complex
should spontaneously evolve at 55 °C toward a more stable dimer
involving all the nucleotides of the stem-loop structure in canonical
base pairs (39). However, the role of the NC protein in this process
has not yet been investigated. The ability of the NC protein to
destabilize nucleic acid structures (41) and to promote nucleic acid
annealing and renaturation (42) should be taken into account when
explaining RNA dimerization in the presence of the protein. In this
report, we analyze the role of a synthetic NCp7 in the in
vitro dimerization process of HIV-1Lai RNA
transcripts.
MATERIALS AND METHODS
Molecular Clones
Details of the pDM2, pDM3, pDM6, and pDM7
plasmid constructions are given elsewhere (35).
RNA Transcripts 77-402, 224-402, 224-296, 296-402, and
224-402DEL
HaeIII and RsaI restriction
enzymes were obtained from New England Biolabs. The pDM3 plasmid was
digested by HaeIII and transcribed by T7 RNA polymerase and
gave rise to a transcript starting from position 77 of the genomic
HIV-1Lai RNA sequence and ending at position 402. This
transcript will be referred to as RNA 77-402 (Fig. 5).
Fig. 5.
Effect of the NCp7 protein on in
vitro dimerization of shorter HIV-1Lai RNA
transcripts. A, Representation of the 5 -end of
HIV-1Lai genomic RNA. TAR, trans-activating
responsive element; PBS, primer tRNALys3 binding
site; sd, splice donor site; and AUG, initiation
codon for Pr55gag synthesis. HIV-1*,
5 -packaging signal of HIV-1 recently described by Clever et
al. (40). Numbering is in relation to the genomic RNA cap site
(+1). The restriction sites of interest are indicated:
HindIII (+77), SacI (+224),
RsaI (+296), and HaeIII (+402). B, HIV-1Lai RNA transcripts
used in this study. RNA transcripts presented here were generated
in vitro as described under "Materials and Methods."
RNA dimer columns, levels of dimeric RNA produced in NC
buffer at 37 °C for 15 min in the absence ( ) or presence (+NCp7) of the NCp7 protein after SDS-phenol treatment. ,
0-5%; +/ , 10-20%; ++, 60-70%; +++, 100%. (mean values from at
least three experiments). C, agarose gel electrophoresis of
shorter HIV-1Lai RNA transcripts. The RNAs are numbered as
in B. Heat-denatured RNAs were incubated in the NC buffer in
the absence ( ) or presence (+) of NCp7 for 15 min at 37 °C. The
NCp7/RNA ratio is 20. All samples were submitted to SDS-phenol
treatment as described under "Materials and Methods" before being
analyzed on the gel. Lane M, monomeric form of RNAs.
[View Larger Version of this Image (18K GIF file)]
The pDM2 plasmid was digested by either HaeIII or
RsaI and transcribed by T7 RNA polymerase and gave rise to
transcripts starting from position 224 of the genomic
HIV-1Lai RNA sequence and ending at positions 402 and 296, respectively. These transcripts will be referred to as RNA 224-402 and
RNA 224-296 transcripts (Fig. 5).
The pDM6 plasmid was digested by HaeIII and transcribed by
T7 RNA polymerase and gave rise to transcripts starting from position 296 of the genomic HIV-1Lai RNA sequence and ending at
positions 402. This transcript will be referred to as RNA 296-402
(Fig. 5).
The pDM7 plasmid, first digested by HaeIII, was transcribed
with T7 RNA polymerase and gave rise to RNA transcript 224-402DEL, devoid of nucleotides 257-266 (Fig. 5).
In Vitro RNA Synthesis and Purification
Experimental
procedures for the HIV-1Lai RNA transcript production and
purification are given elsewhere (35, 39).
Synthetic Nucleocapsid Protein
Solid phase synthesis of
HIV-1 NCp7 protein, consisting of 72 amino acids, was performed as
described previously (43).
Stock solutions of NCp7 were conserved at 10 3
M and 4 °C in Milli-Q water (Millipore) containing three
equivalent molar concentrations of ZnSO4.
HIV-1 RNA Transcript Dimerization Assays in the Presence of the
NCp7
In a standard dimerization assay, RNA in 14 µl of Milli-Q
water was heated for 2 min at 90 °C, chilled on ice for 2 min, and adjusted to 20 µl with 4 µl of 5 × NC buffer containing 100 mM Tris-HCl, pH 7.5, 250 mM NaCl, 25 mM dithiothreitol, and 1 mM MgCl2
and 2 µl of 10 × NCp7 solution, i.e. 17.5 protein
molecules/RNA strand, (or poly-L-lysine) or polyethylene
glycol 8000 or 2 µl of Milli-Q water). Poly-L-lysine and
polyethylene glycol 8000 were purchased from
Sigma.
The samples were incubated for 15 min at 37 °C or at temperatures
ranging from 10 to 60 °C. At the end of incubation, all the samples
were cooled on ice for 2 min, placed for 2 min at room temperature, and
then mixed with 10 µl of water and 3 µl of 5% SDS for 5 more min
at room temperature. The RNA transcripts were phenol extracted for
deproteinization with 30 µl of phenol saturated by 40 mM
Tris-HCl, pH 6.5, 0.1% SDS, and 2.5 mM EDTA. Three µl of
loading buffer (50% (w/v) glycerol and 0.025% (w/v) tracking dyes)
were then added, and the samples were loaded on a 1.5% Sea Kem agarose
gel and electrophoresed at 5 V/cm and 4 °C in buffer containing 50 mM Tris-borate, pH 8.3, 1 mM EDTA, and 0.2 µg/ml ethidium bromide. Monomeric RNA transcripts were obtained at
20 °C in a buffer containing 10 mM Tris-HCl, pH 7.5.
Melting Temperature (Tm) Determination of Dimer
Dissociation
After denaturation at 90 °C for 2 min in
nuclease-free water, the RNA was incubated in a buffer containing 50 mM Tris-HCl, pH 7.5, and 100 mM NaCl (dimer
buffer) at a strand concentration of 0.8 µM at either
37 °C or 55 °C for 90 min for optimal dimerization (35). The
resulting dimers, D37 (unstable dimer) and D55 (stable dimer), were
then dialyzed (Millipore V6 filters, 0.025 µm) for 2 h at
4 °C against 1 × NC buffer containing 20 mM
Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM
dithiothreitol, and 0.2 mM MgCl2. Unstable dimer was then incubated in the presence of NCp7 (i.e. 1 molecule of the protein per 20 nt of RNA 77-402) for 15 min at
37 °C. Both dimers were then treated with SDS-phenol, as described
above, for deproteinization, and 20-µl aliquots of each sample were
then incubated for 5 min at varying temperatures ranging from 10 to 65 °C and electrophoresed as described above. After fluorescent scanning of the gels using a Bioprofil apparatus (Vildber Lourmat, Marne La Vallee, France), the percentage of dimer and monomer was
estimated. The percentage of the dimer was defined as the area of the
dimer peak divided by the sum of the areas of monomer and dimer peaks.
The Tm was estimated from the plot of the amount of the dimer as a
function of temperature.
Antisense DNA Oligonucleotide Experiments
Purified
synthetic DNA oligonucleotides complementary to positions 251-267 of
the HIV-1Lai sequence (oligonucleotide 257B, 5 -GCCGTGCGCGCTTCAGC3- ) and to positions 268-284 of the
HIV-1Mal sequence (35, 39) (oligonucleotide 257 M, used as a control oligonucleotide, differs from 257B by
4 nt,
5 GC GTG GC C TCAGC3 ) were obtained from Genosys, Inc. Numbering is relative to the genomic
RNA cap site (+1).
DNA oligonucleotides were 5 -32P-labeled with
[ -32P]ATP (Amersham, Corp.) and T4 polynucleotide
kinase (Boehringer Mannheim). The specific radioactivity was about
105 cpm/µg DNA oligonucleotide.
RNA 77-402 was heat-denatured in the presence of the
32P-DNA oligonucleotide before starting the in
vitro dimerization process. NCp7 was then added with the NC buffer
as described above. After a SDS-phenol treatment, 32P-DNA
oligonucleotide-RNA complexes were analyzed by 1.5% agarose gel
electrophoresis. After staining with ethidium bromide and photography,
the gel was fixed for 10 min in 10% trichloroacetic and dried for 40 min under vacuum at room temperature. Hybridization of the
32P-DNA oligonucleotide to monomeric and dimeric RNA
77-402 was detected by autoradiography of the corresponding gel.
RNA Secondary Structure Analysis
RNA secondary structures
were predicted with the MFOLD program, which uses the energy
minimization method of Zucker (44) and energy rules developed by Turner
et al. (45).
The secondary structure of the HIV-1Lai 240-280 region
within the RNA 77-402 transcript was confirmed by enzymatic probing (39).
RESULTS
NCp7 Activates HIV-1Lai RNA 77-402
Dimerization
In vitro dimerization of the
HIV-1Lai RNA 77-402 transcript was performed in the
presence of varying amounts of NCp7. After dimerization, the dimer was
deproteinized and analyzed by agarose gel electrophoresis. Fig.
1A shows that although the RNA 77-402 transcript incubated alone migrates mainly as a monomer (lane D, around 15-20% of dimer), in the presence of NCp7, the monomer disappears to give rise to a RNA dimer together with a small amount of
higher order multimers (lanes 1/20, 1/10, 1/5, and
1/2). It should be noted, for purposes of comparison, that
the dimer samples obtained in the presence or absence of the protein
were submitted to the same deproteinization step. Under these
conditions, NCp7 activates RNA 77-402 dimerization, and this
activation is almost complete for an NCp7 to RNA ratio of at least 1 NCp7 molecule/20 nt (Fig. 1A, lane 1/20). This result is in
accordance with several previous works in which retroviral NC was found
to activate retroviral RNA dimerization in vitro (2, 21,
27).
Fig. 1.
HIV-1Lai RNA 77-402 dimerization
is specifically activated by NCp7. A, heat-denatured RNAs
were incubated in the NC buffer at 37 °C in the absence (lane
D) or presence of 1 molecule of NCp7/50, 20, 10, 5, or 2 nt of RNA
77-402. B, heat-denatured RNAs were incubated in the NC
buffer at 37 °C in the absence (lane D) or presence of 1 molecule of poly-L-lysine (PolyLYS)/20, 10, or 5 nt of RNA 77-402 or 1-10% of polyethylene glycol 8000 (PEG8000) in
the samples. RNA 77-402 can be seen in a monomeric form at 20 °C in
a buffer containing 10 mM Tris-HCl, pH 7.5 (lanes
M). Samples, after treatment with SDS-phenol, were analyzed by
ethidium bromide-stained 1.5% agarose gel electrophoresis. Monomer,
dimer, and multimers of RNA 77-402 are indicated.
[View Larger Version of this Image (29K GIF file)]
The specificity of this activation process was tested by using
poly-L-lysine instead of NCp7 in the same dimerization
assay. This peptide, a highly basic polypeptide, was unable to activate RNA 77-402 dimerization efficiently (Fig. 1B, lanes 1/20,
1/10, and 1/5); the percentage of dimer remained the
same as in the RNA control (Fig. 1B, lane D). However,
multimers were induced by poly-L-lysine (Fig. 1B,
lanes 1/20, 1/10, and 1/5). This could result from
electrostatic binding of the basic polypeptides to the RNA molecules.
In the case of NCp7, at ratios higher than 1/50 protein/nt, such a
multimerization occurs (Fig. 1A, lanes 1/20, 1/10, 1/5, and
1/2), but we observed a difference between the migration of
the multimers formed in the presence of NCp7 and the migration of those
formed in the presence of poly-L-lysine. This difference
could be due to the fact that in the presence of
poly-L-lysine, we observed an aggregation process leading
to trimers, tetramers, pentamers, etc., whereas in the presence of NCp7, the multimers seem to correspond to multimerization of dimers leading to tetramers and even higher order structures, i.e.
hexamers and octamers. Also, we observed a decrease of multimer content (at least from ratio 1/20 to 1/5; Fig. 1A), which may be due
to the fact that as the concentration of NCp7 increases, the protein coats the RNA, and the interaction between RNA molecules may not be as
efficient. We also tested the influence of polyethylene glycol on the
dimerization process, since polyethylene glycol is known to enhance the
rate of hybridization of nucleic acids (46). Increasing amounts of
polyethylene glycol did not have a detectable effect on RNA 77-402
dimerization (Fig. 1B, lanes 1, 5, and 10%).
To characterize further the dimerization process, the kinetics of RNA
77-402 dimerization were investigated (data not shown). In the
presence of NCp7, dimerization was complete after 5 min at 37 °C,
and no kinetic profile was observed whatever the protein concentration.
These results are in accordance with those presented by Darlix and
co-workers (2) with the NCp15 protein and indicate that NCp7 probably
does not function in a catalytic manner.
Effect of the NCp7 on the Dimerization Process as a Function of the
Temperature
We analyzed the effect of the temperature on
spontaneous in vitro dimerization of HIV-1Lai
RNA 77-402 (Fig. 2A). On incubation in the
NC buffer, spontaneous dimerization of RNA 77-402 occurred. Up to
37 °C, about 60% of the RNA was dimeric (Fig. 2A, lanes 20, 30, and 37), whereas between 45 and 50 °C, this
dimer dissociated (Fig. 2A, lanes 45 and 50).
This dissociation led to the formation of two monomeric conformers (m
and m ), the nature of which remains unknown. For temperatures higher
than 50 °C, some dimer reappeared when m disappeared (Fig.
2A, lanes 55 and 60). The same results were
observed in dimer buffer while characterizing the spontaneous in
vitro RNA 77-402 dimerization process (39), and, as previously shown, one of these dimers, formed at 37 °C, was termed D37 and identified as an unstable kissing complex, resulting from the loop-loop
interaction of the autocomplementary
G257CGCGC262 sequence. The other dimer, formed
at 55 °C, was termed D55 and corresponded to a more stable
double-stranded structure.
Fig. 2.
RNA 77-402 dimer formation with or without
NCp7 as a function of temperature. Experimental conditions are 20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM dithiothreitol, 0.2 mM MgCl2,
and 1 molecule of NCp7/20 nt of RNA. The total RNA strand concentration
is 0.8 µM. d, dimer; m, monomer;
m , monomer that migrates differently in the gel.
Heat-denatured RNAs were incubated in the NC buffer at temperatures
between 10 and 60 °C, without any protein (A and B) or in the presence of NCp7 (C) for 15 min.
Samples, untreated by SDS-phenol (A) or after treatment with
SDS-phenol (B and C), were analyzed by ethidium
bromide-stained 1.5% agarose gel electrophoresis.
[View Larger Version of this Image (57K GIF file)]
Samples required SDS-phenol treatment, before gel analysis, in the
presence of the NCp7 protein. Thus, RNA 77-402 dimerization was
investigated as a function of the temperature in the absence of NCp7
but in NC buffer followed by SDS-phenol treatment (Fig. 2B).
Under these conditions, dimerization, observed without SDS-phenol treatment between 20 and 37 °C (Fig. 2A), no longer
occurred (Fig. 2B, lanes 20 and 37). This
suggests that the kissing complex was not stable enough to resist such
treatment and that only the dimer formed at 55 °C was stable enough
to remain intact (Fig. 2B, lanes 55 and 60).
Then, the experiment was performed in the presence of the NCp7
nucleocapsid protein to observe the effect of this protein on dimer
formation (Fig. 2C). NCp7 promoted complete RNA 77-402 dimerization at temperatures ranging from 30 to 60 °C (Fig.
2C). Dimer instability, triggered with SDS-phenol treatment
(Fig. 2B) and occurring in the 45-50 °C range (Fig.
2A), had disappeared in the presence of the protein (Fig.
2C). This could signify that NCp7 promotes the formation of
a unique dimer able to support deproteinization (Fig. 2C, lanes
20-60) and strongly suggests that the dimer formed in the
presence of NCp7 is the same as the one observed at 55 °C in its
absence. We were eager to check whether NCp7 was capable of converting
the unstable kissing complex into the stable dimer.
NCp7 Converts an Unstable Dimer into a Stable One
The thermal
stability of the dimer formed at 55 °C, in the absence of the
protein, was compared with that of the kissing complex submitted to
NCp7 activity (Fig. 3). The unstable dimer, D37, and the
stable dimer, D55, were formed in the dimer buffer and then dialyzed
against the NC buffer so that experiments in the presence of the
protein could be performed. The unstable dimer, D37, was incubated with
NCp7 for 15 min at 37 °C, but not the stable one. Both dimers were
then submitted to deproteinization by SDS-phenol treatment before the
thermal denaturation experiment. Agarose gels corresponding to these
experiments are shown (Fig. 3A) together with the
denaturation curves (Fig. 3B). Interestingly enough, both
dimers had the same Tm value of 35-36 °C in NC buffer after
SDS-phenol treatment, whereas the kissing complex formed at 37 °C
under the same conditions without NCp7 had disappeared (Fig. 2B,
lane 37). These results show that both dimers have the same
stability and therefore are likely the same. It is noteworthy that the
temperature obtained for the Tm value was low (35-36 °C) compared
with the temperature value required for the formation of the stable
dimer (55 °C). This difference was certainly due to the presence of
residual phenol in the samples after SDS-phenol treatment just before
conducting the thermal denaturation experiment, since phenol is known
to have an effect on the stability of double stranded DNA (47) or
retroviral RNA (48), by decreasing the Tm value.
Fig. 3.
Thermal stability of the RNA 77-402 dimer
formed either at 37 °C in the presence of the NCp7 or at 55 °C in
the absence of the NCp7. After in vitro RNA 77-402
dimerization in the dimer buffer at either 37 or 55 °C, the unstable
and stable dimers were dialyzed against NC buffer. The unstable one was
incubated with the protein (1 molecule of NCp7/20 nt) for 15 min at
37 °C, whereas the other was not. The two resulting dimers were then submitted to SDS-phenol treatment, and aliquots of each were incubated 5 min at the indicated temperatures. Samples were analyzed by 1.5%
agarose gel electrophoresis, and the percent of each species was
determined from the gel. The temperatures on the plot correspond to the
temperatures shown above the gels. d, dimer; m,
monomer.
[View Larger Version of this Image (22K GIF file)]
Inhibition of HIV-1Lai RNA 77-402 Dimerization by an
Oligomer in the Presence of the NCp7 Protein
We previously
defined a complementary DNA oligonucleotide, oligomer 257B, which
targets the HIV-1Lai sequence 257-262 containing nucleotides G257CGCGC262 and totally inhibits
the dimerization process of the two RNA 77-402 dimers (D37 and D55) at
an oligonucleotide 257B/RNA ratio of 1/1 (39). We used this
oligonucleotide to interfere with the dimerization process of RNA
77-402 mediated by NCp7 (Fig. 4). Total inhibition of
dimerization was observed for RNA 77-402 dimer, at an oligonucleotide
257B/RNA ratio of 1/1, at 37 °C in the presence of the NCp7 protein
(Fig. 4A, lane 257B), whereas oligomer 257M, used as a
control, was unable to prevent dimer formation of RNA 77-402 (Fig.
4A, lane 257M). Moreover, we checked that oligomer 257B was
only hybridizing to RNA 77-402 in its monomeric form (Fig. 4B,
lane 257B) and that oligomer 257M was not (Fig. 4B, lane
257M).
Fig. 4.
Inhibition of HIV-1Lai RNA
77-402 dimer formation by oligonucleotide 257B in the presence of
NCp7. RNA 77-402 (0.8 µM) was incubated in NC
buffer with 1 molecule of NCp7/20 nt for 15 min at 37 °C in the
absence (lane 0) or presence of 1 molar equivalent of
32P-DNA oligonucleotide 257B (lane 257B) or
32P-DNA oligonucleotide 257M (lane 257M) (see
"Materials and Methods"). Lane M, monomeric form of RNA
77-402; lane D, RNA 77-402 in the NC buffer without any
protein; lane MK, 0.16-1.77-kilobase RNA ladder (Life
Technologies, Inc.). m and d, and dimeric RNAs,
respectively. A, 1.5% agarose gel electrophoresis.
B, autoradiogram of A.
[View Larger Version of this Image (31K GIF file)]
These experiments allow us to conclude that the same autocomplementary
sequence in stem-loop structure 240-280 is involved in dimerization
both in the presence and in the absence of NCp7 (35, 39).
Dimerization of Short HIV-1Lai RNA Transcripts with
NCp7
Previously used RNA transcripts (35) were tested for their
ability to dimerize in the absence or presence of NCp7, at 37 °C, in
the NC buffer (Fig. 5).
RNA transcripts 224-402 and 224-296, containing the stem-loop
structure 240-280, spontaneously dimerized at 60-70% in the NC
buffer (Fig. 5C, ) and completely in the presence of NCp7 (Fig. 5C, +). In contrast, RNA 224-402DEL, devoid of the
G257CGCGCACGG266 sequence (Fig. 5B, RNA
224-402 DEL), was unable to dimerize significantly in the
absence of the protein (Fig. 5C, ) and also in its
presence (Fig. 5C, +). It is noteworthy that the
10-nucleotide deletion did not alter the overall secondary structure of
the molecule despite a modification in the primary sequence of the
stem-loop, which was no longer autocomplementary (35). We also found
that RNA 296-402 (Fig. 5B), which contains four polypurine
tracts, was unable to dimerize significantly in the absence or presence of NCp7 (Fig. 5C, and +).
We therefore conclude that the autocomplementary
G257CGCGC262 sequence in stem-loop structure
240-280 (Fig. 6, Monomer) is necessary for
HIV-1Lai RNA dimer formation in the presence of NCp7, as
described under conditions without the protein (35).
Fig. 6.
Model of NCp7 implication on dimerization
process of HIV-1Lai RNA in vitro.
[View Larger Version of this Image (19K GIF file)]
DISCUSSION
This work aimed at elucidating the role of NCp7 in the in
vitro dimerization process of HIV-1Lai RNA. We have
previously proposed a model of spontaneous in vitro
dimerization of transcript RNA 77-402 under conditions of low ionic
strength (39). This model, which has been confirmed by another recent
study (49), suggests the formation of a kissing complex at 37 °C,
which is converted into a stable dimer only if the temperature is
increased to 55 °C. Those two entities, D37 and D55, are involved in
HIV-1Lai RNA dimer formation, and we have proposed NCp7 as
the trigger provoking the conformational change that causes the kissing
complex to be transformed at 37 °C into the stable double stranded
dimer (Fig. 6).
We report here that NCp7 was capable of activating RNA 77-402
transcript dimerization (Fig. 1), within a 20 to 60 °C range, at 50 mM NaCl, pH 7.5 (Fig. 2C). These results confirm
that NC protein from HIV-1 activates HIV-1 RNA dimerization in
vitro (2, 21) at NC/RNA ratios equal to or higher than 1/50. When
the NC/RNA ratio reaches 1/20, NCp7-promoted dimerization is complete (Fig. 1A). The fact that NCp7 was inactive at temperatures
lower than 20 °C (Fig. 2C, lanes 10 and 20)
could be due to the very strong stability of the stems in the kissing
complex, suggesting that the protein would be incapable of
destabilizing these stems at temperatures lower than 20 °C.
More important is the finding that, at 37 °C, NCp7 is able to
convert the unstable dimer, corresponding to the kissing complex previously described (39), into a stable dimer (Fig. 3), the stability
of which corresponds to that of D55. This suggests that NCp7 interacts
with the kissing complex to allow this conversion, which does not
spontaneously occur at 37 °C without the protein. The recognition of
such a loop-loop complex by NCp7 is a process comparable with that
found in the Rom protein. This bacterial protein facilitates
sense-antisense RNA pairing by binding to the transiently formed
hairpin pairs of RNA I and complementary RNA II (50, 51).
NCp7-dependent dimerization of HIV-1 RNA has already been
investigated. Sakagushi et al. (27) described a specific
nucleotide region required for NCp7 binding and RNA dimerization, which
is the same as the one previously described by Darlix et al.
(2). However, the model proposed by Sakagushi et al. (27) is
not in accordance with the data presented here, since RNA 296-402, which corresponds to RNA 311-415 of HIV-1Mal described by
Darlix et al. (2) and which contains the 44-nt RNA described
by Sakagushi et al. (27), is unable to dimerize
significantly with or without NCp7 (Fig. 5). In contrast, dimerization
mediated by NCp7 of HIV-1Mal RNA 1-415, described by De
Rocquigny et al. (21), is in accordance with our results.
This RNA transcript contains the entire sequence of the corresponding
HIV-1Lai RNA 77-402 transcript.
We found that the autocomplementary
G257CGCGC262 sequence in stem-loop structure
240-280 (Fig. 6, Monomer) is necessary for
HIV-1Lai RNA dimer formation in the presence of NCp7 (Fig.
5), and that NCp7 is able to promote RNA 77-402 dimerization at
50 °C, whereas in the absence of the protein, no dimer is found
(Fig. 2). Because the RNA annealing between the two monomers happens
spontaneously without NCp7 (Fig. 2A), these results are more
in favor of a specific action of NCp7 on the kissing complex to convert
it into a stable dimer rather than in promoting the loop-loop
interaction driven by the GCGCGC sequence and the stem-loop structure
of the RNA molecule. However, considering our results, we cannot
definitively exclude that Ncp7 might promote the formation of the
stable dimer directly from the monomer (Fig. 6, Monomer D55). To determine whether NCp7 would specifically recognize
the 240-280 stem-loop structure, we tried to identify a site on the
protein exhibiting a high affinity for the 240-280 stem-loop structure
by gel retardation assay of NCp7 binding to the HIV-1 RNA transcript.
No significant difference was found in NCp7 binding affinity to RNA
224-402 and RNA 224-402DEL (data not shown). However, both RNA
transcripts had the NC binding site described by Sakagushi et
al. (27) in their sequences. At the present time, experiments with
shorter or mutated RNA transcripts are under way with gel retardation assays.
NC protein was reported to possess nucleic acid unwinding (41, 52) and
renaturation (42) activities. Thus, RNA-RNA recognition would first
occur via the autocomplementary G257CGCGC262
sequence to form the kissing complex, and then, once bound to this
transient complex, NCp7 would open both stems of the complex to permit
the formation of the double stranded dimer (Fig. 6). Both activities of
the protein are required to explain a RNA dimerization specifically
activated by NCp7, since no other proteins, at least those known for
their nucleic acid-annealing activity, are able to promote this process
(2, 26). As described previously (39), in the absence of the protein,
conversion of D37 into D55 is only possible when the temperature is
increased to above 55 °C. In contrast, at 37 °C, NCp7 alone is
capable of overcoming this major energy barrier and converting the
kissing complex into the stable dimer. In light of these findings, we
can propose the model described in Fig. 6.
As already reported, an autocomplementary sequence located in the loop
of such a stem-loop structure has already been found downstream from
the PBS of several other retroviral RNA genomes (36, 53).2
This strongly supports the concept that all retroviruses could have the
involvement of this RNA structure in their dimerization process in
common. If this were true, NC proteins of other retroviruses could be
proposed as having the same mechanism of action as NCp7 does on
HIV-1Lai RNA dimerization. Girard et al. (54)
have just reported that NCp10 activates in vitro
dimerization of Moloney murine leukemia virus RNA transcripts, which
contain the autocomplementary stem-loop structure 283-298.
Furthermore, the nucleocapsid proteins of various species could be
exchangeable for this process, since NCp10 of Moloney murine leukemia
virus and NCp12 of Rous sarcoma virus are capable of promoting HIV-1
RNA dimerization in vitro (2).
It has been suggested that the dimerization and encapsidation processes
are linked, since encapsidation of the retroviral genome is governed by
specific interactions between the NC domain of gag and the
encapsidation-dimerization sequence (for review, see Ref. 3). It is
noteworthy that the 240-280 stem-loop structure is located within the
5 -RNA-packaging signal of HIV-1 described recently by Clever et
al. (40). Given our model, an appealing concept is that the NC
protein could be a link between dimerization and encapsidation via the
240-280 RNA stem-loop structure. This structure could be a site for NC
binding, among others described (2, 17, 18, 27), and perhaps a
determinant for the encapsidation signal.
Our results also suggest that NCp7 may control HIV-1 RNA dimer
maturation, and this would extend the role of the NC protein in
vitro to one of its functions in the retroviral life cycle. Indeed, it has been reported that the genomic RNA dimer appears to be
initially encapsidated in an extended conformation and then adopts a
condensed structure (34, 3, and references therein). The authors
suggested that dimeric RNA of HIV-1 (34) undergoes a change in
conformation, which they termed a maturation event, after releasing the
virus from the cell. Such a RNA maturation step would correlate with
the cleavage of Gag precursor molecules by the viral protease and
therefore with the presence of the processed nucleocapsid protein (34).
The same authors found that an immature dimeric RNA isolated from
protease-negative mutant virions dissociates into monomers at a lower
temperature than the mature wild-type dimer. It has also been reported
that the linkage between subunits of B77 sarcoma virus RNA is
stabilized as a function of time during extracellular virion maturation
(48). In this case, RNA monomers are linked by unstable base pair
regions in the immature dimer, which are disrupted during RNA phenol
extraction. This observation is reminiscent of that found with the
kissing complex, an unstable dimer that dissociates after SDS-phenol
treatment and could correspond to such an immature dimer. These results
are consistent with our in vitro model of the HIV-1 RNA
dimerization process. In the absence of the protein, the HIV-1 RNA
transcript forms an unstable dimer, namely the one that totally
dissociates at room temperature during phenol extraction (Fig.
2B). Under the effect of NCp7, this dimer then undergoes a
change in conformation to become more stable (Fig. 3). This change can
be considered the first step of the dimer maturation event if indeed
this step corresponds to a stabilization of the 240-280-base pair
region (Fig. 6). In this manner, NCp7 would also promote the
stabilization of other RNA-RNA interactions occurring along the genomic
RNA, which certainly exist during nucleocapsid maturation, once the
virus has been released from the cell. Our results lead to a simple
model system in which the molecular and structural aspects of the RNA
dimerization process and NCp7-mediated RNA maturation can be studied in
detail.
However, when we propose that NCp7 plays the same role in
vivo as in vitro, we should be aware that we cannot
exclude the possibility that in vivo there may be some other
accessory factors that could aid in the formation of this stable
dimer.
FOOTNOTES
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by a fellowship from the Agence Nationale de la
Recherche sur le SIDA.
¶
To whom correspondence should be addressed.
1
The abbreviations used are: NCp, nucleocapsid
protein; HIV, human immunodeficiency virus; Tm, melting temperature;
nt, nucleotide; DEL, deletion.
2
P. Fossé, unpublished observations.
Acknowledgments
We thank Dr. P. Fossé (Institut Gustave
Roussy) for helpful discussions and comments on the manuscript and L. Saint Ange (Institut Gustave Roussy) for editing the manuscript.
REFERENCES
-
Coffin, J. M.
(1984)
in
RNA Tumor Viruses (Weiss, R., Teich, N., Varmus, H., and Coffin, J., eds), Vol. 1, pp. 261-368, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Darlix, J.-L., Gabus, C., Nugeyre, M.-T., Clavel, F., and Barré-Sinoussi, F.
(1990)
J. Mol. Biol.
216,
689-699
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Darlix, J.-L., Lapadat-Tapolsky, M., de Rocquigny, H., and Roques, B. P.
(1995)
J. Mol. Biol.
254,
523-537
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dickson, C., Eisenman, R., Fan, H., Hunter, E., and Reich, N. (1985) in
RNA Tumor Viruses (Weiss, R., Teich, N., Varmus, H., Coffin,
J., eds) Part 2, pp. 513-648, Cold Spring Harbor Laboratory, Cold
Spring Harbor, NY
-
Covey, S. N.
(1986)
Nucleic Acids Res.
14,
623-633
[Medline]
[Abstract/Free Full Text]
-
Mély, Y., Cornille, F., Fournié-Zaluski, M. C., Darlix, J.-L., Roques, B. P., and Gérard, D.
(1991)
Biopolymers
31,
899-906
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Berg, J.
(1986)
Science
232,
485-487
[Medline]
[Abstract/Free Full Text]
-
South, T. L., and Summers, M. F.
(1993)
Protein Sci.
2,
3-19
[Medline]
[Medline]
[Order article via Infotrieve]
-
Morellet, N., Jullian, N., De Rocquigny, H., Maigret, B., Darlix, J.-L., and Roques, B. P.
(1992)
EMBO J.
11,
3059-3065
[Medline]
[Medline]
[Order article via Infotrieve]
-
Morellet, N., De Rocquigny, H., Mély, Y., Jullian, N., Déméné, H., Ottmann, M., Gérard, D., Darlix, J.-L., Fournié-Zaluski, M.-C., and Roques, B. P.
(1994)
J. Mol. Biol.
235,
287-301
[Medline]
[Medline]
[Order article via Infotrieve]
-
Déméné, H., Dong, C. Z., Ottmann, M., Rouyez, M. C., Jullian, N., Morellet, N., Mély, Y., Darlix, J. L., Fournié-Zaluski, M. C., Saragosti, S., and Roques, B. P.
(1994)
Biochemistry
33,
11707-11716
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mély, Y., Jullian, N., Morellet, N., De Rocquigny, H., Dong, C. Z., Piemont, E., Roques, B. P., and Gérard, D.
(1994)
Biochemistry
33,
12085-12091
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Méric, C., Gouilloud, E., and Spahr, P.-F.
(1988)
J. Virol.
62,
3328-3333
[Medline]
[Abstract/Free Full Text]
-
Aldovini, A., and Young, R. A.
(1990)
J. Virol.
64,
1920-1926
[Medline]
[Abstract/Free Full Text]
-
Gorelick, R. J., Nigida, S. M., Jr., Bess, J. W., Jr., Arthur, L. O., Henderson, L. E., and Rein, A.
(1990)
J. Virol.
64,
3207-3211
[Medline]
[Abstract/Free Full Text]
-
Ottmann, M., Gabus, C., and Darlix, J.-L.
(1995)
J. Virol.
69,
1778-1784
[Medline]
[Abstract]
-
Berkowitz, R. D., Ohagen, A., Höglund, S., and Goff, S. P.
(1995)
J. Virol.
69,
6445-6456
[Medline]
[Abstract]
-
Dannull, J., Surovoy, A., Jung, G., and Moelling, K.
(1994)
EMBO J.
13,
1525-1533
[Medline]
[Medline]
[Order article via Infotrieve]
-
Prats, A.-C., Sarih, L., Gabus, C., Litvak, S., Keith, G., and Darlix, J.-L.
(1988)
EMBO J.
7,
1777-1783
[Medline]
[Medline]
[Order article via Infotrieve]
-
Barat, C., Lullien, V., Schatz, O., Keith, G., Nugeyre, M. T., Grüninger-Leitch, F., Barré-Sinoussi, F., Le Grice, S. F. J., and Darlix, J.-L.
(1989)
EMBO J.
8,
3279-3285
[Medline]
[Medline]
[Order article via Infotrieve]
-
De Rocquigny, H., Gabus, C., Vincent, A., Fournié-Zaluski, M.-C., Roques, B., and Darlix, J.-L.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
6472-6476
[Medline]
[Abstract/Free Full Text]
-
Darlix, J.-L., Vincent, A., Gabus, C., De Rocquigny, H., and Roques, B.
(1993)
C. R. Acad. Sci. Paris
316,
763-771
[Medline]
-
Lapadat-Tapolsky, M., De Rocquigny, H., Van Gent, D., Roques, B., Plasterk, R., and Darlix, J.-L.
(1993)
Nucleic Acids Res.
21,
831-839
[Medline]
[Abstract/Free Full Text]
-
You, J. C., and McHenry, C. S.
(1994)
J. Biol. Chem.
269,
31491-31495
[Medline]
[Abstract/Free Full Text]
-
Tsuchihashi, Z., and Brown, P. O.
(1994)
J. Virol.
68,
5863-5870
[Medline]
[Abstract/Free Full Text]
-
Lapadat-Tapolsky, M., Pernelle, C., Borie, C., and Darlix, J.-L.
(1995)
Nucleic Acids Res.
23,
2434-2441
[Medline]
[Abstract/Free Full Text]
-
Sakagushi, K., Zambrano, N., Baldwin, E. T., Shapiro, B. A., Erickson, J. E., Omichinski, J. G., Clore, G. M., Gronenborn, A. M., and Appela, E.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5219-5223
[Abstract/Free Full Text]
-
Bender, W., Chien, Y. H., Chattopadkyay, S., Vogt, P. K., Gardner, M. R., and Davidson, N.
(1978)
J. Virol.
25,
888-896
[Medline]
[Abstract/Free Full Text]
-
Murti, K. G., Bondurant, M., and Tereba, A.
(1981)
J. Virol.
37,
411-419
[Medline]
[Abstract/Free Full Text]
-
Marquet, R., Baudin, F., Gabus, C., Darlix, J. L., Mougel, M., Ehresmann, C., and Ehresmann, B.
(1991)
Nucleic Acids Res.
18,
2349-2357
-
Awang, G., and Sen, D.
(1993)
Biochemistry
32,
11453-11457
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sundquist, W., and Heaphy, S.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3393-3397
[Medline]
[Abstract/Free Full Text]
-
Berkout, B., Oude Essink, B. B., and Schoneveld, I.
(1993)
FASEB J.
7,
181-187
[Abstract]
-
Fu, W., Gorelick, R. J., and Rein, A.
(1994)
J. Virol.
68,
5013-5018
[Medline]
[Abstract/Free Full Text]
-
Muriaux, D., Girard, P.-M., Bonnet-Mathonière, B., and Paoletti, J.
(1995)
J. Biol. Chem.
270,
8209-8216
[JBC][Medline]
[Abstract/Free Full Text]
-
Girard, P.-M., Bonnet-Mathonière, B., Muriaux, D., and Paoletti, J.
(1995)
Biochemistry
34,
9785-9794
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Skripkin, E., Paillart, J. C., Marquet, R., Ehresmann, B., and Ehresmann, C.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
4945-4949
[Medline]
[Abstract/Free Full Text]
-
Laughrea, M., and Jetté, L.
(1994)
Biochemistry
33,
13464-13474
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Muriaux, D., Fossé, P., and Paoletti, J.
(1996)
Biochemistry
35,
5075-5082
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Clever, J., Sassetti, C., and Parslow, T. G.
(1995)
J. Virol.
69,
2101-2109
[Medline]
[Abstract]
-
Khan, R., and Giedroc, D. P.
(1992)
J. Biol. Chem.
267,
6689-6695
[Medline]
[Abstract/Free Full Text]
-
Dib-Hajj, F., Khan, R., and Giedroc, D. P.
(1993)
Protein Sci.
2,
231-243
[Medline]
[Medline]
[Order article via Infotrieve]
-
De Rocquigny, H., Ficheux, D., Gabus, C., Fournié-Zaluski, M.-C., Darlix, J.-L., and Roques, B.
(1991)
Biochem. Biophys. Res. Commun.
180,
1010-1018
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zucker, M.
(1989)
Science
244,
48-52
[Abstract/Free Full Text]
-
Turner, D. H., Sugimoto, N., and Freier, S. M.
(1988)
Annu. Rev. Biophys. Biophys. Chem.
17,
167-192
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Maniatis, T., Fritsch, E. F., and Sambrook, J.
(1982)
Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Massie, H. R., and Zimm, B. H.
(1965)
Proc. Natl. Acad. Sci. U. S. A.
54,
1641-1643
[Free Full Text]
-
Stoltzfus, C. M., and Snyder, P. N.
(1975)
J. Virol.
16,
1161-1170
[Medline]
[Abstract/Free Full Text]
-
Laughrea, M., and Jetté, L.
(1996)
Biochemistry
35,
1589-1598
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Egushi, Y., and Tomizawa, J.
(1990)
Cell
60,
199-209
[CrossRef][Medline]
[Order article via Infotrieve]
-
Predki, P. F., Nayak, L. M., Gottlieb, M. B. C., and Regan, L.
(1995)
Cell
80,
41-50
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Priel, E., Aflalo, E., Seri, I., Henderson, L. E., Arthur, L. O., Aboud, M., Segal, S., and Blair, D. G.
(1995)
FEBS Lett.
362,
59-64
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Feng, Y., Fu, W., Winter, A. J., Levin, J. G., and Rein, A.
(1995)
J. Virol.
69,
2486-2490
[Medline]
[Abstract]
-
Girard, P.-M., de Rocquigny, H., Roques, B., and Paoletti, J.
(1996)
Biochemistry
35,
8705-8714
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Bernacchi, S. Freisz, C. Maechling, B. Spiess, R. Marquet, P. Dumas, and E. Ennifar
Aminoglycoside binding to the HIV-1 RNA dimerization initiation site: thermodynamics and effect on the kissing-loop to duplex conversion
Nucleic Acids Res.,
December 18, 2007;
35(21):
7128 - 7139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sinck, D. Richer, J. Howard, M. Alexander, D. F.J. Purcell, R. Marquet, and J.-C. Paillart
In vitro dimerization of human immunodeficiency virus type 1 (HIV-1) spliced RNAs
RNA,
December 1, 2007;
13(12):
2141 - 2150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. T. Baig, J.-M. Lanchy, and J. S. Lodmell
HIV-2 RNA dimerization is regulated by intramolecular interactions in vitro
RNA,
August 1, 2007;
13(8):
1341 - 1354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Henriet, L. Sinck, G. Bec, R. J. Gorelick, R. Marquet, and J.-C. Paillart
Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription
Nucleic Acids Res.,
August 1, 2007;
35(15):
5141 - 5153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Moore, W. Fu, O. Nikolaitchik, J. Chen, R. G. Ptak, and W.-S. Hu
Dimer Initiation Signal of Human Immunodeficiency Virus Type 1: Its Role in Partner Selection during RNA Copackaging and Its Effects on Recombination
J. Virol.,
April 15, 2007;
81(8):
4002 - 4011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mujeeb, N. B. Ulyanov, S. Georgantis, I. Smirnov, J. Chung, T. G. Parslow, and T. L. James
Nucleocapsid protein-mediated maturation of dimer initiation complex of full-length SL1 stemloop of HIV-1: sequence effects and mechanism of RNA refolding
Nucleic Acids Res.,
March 19, 2007;
35(6):
2026 - 2034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Sun, Q. Zhang, and H. M. Al-Hashimi
Resolving fast and slow motions in the internal loop containing stem-loop 1 of HIV-1 that are modulated by Mg2+ binding: role in the kissing-duplex structural transition
Nucleic Acids Res.,
March 12, 2007;
35(5):
1698 - 1713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bernacchi, E. Ennifar, K. Toth, P. Walter, J. Langowski, and P. Dumas
Mechanism of Hairpin-Duplex Conversion for the HIV-1 Dimerization Initiation Site
J. Biol. Chem.,
December 2, 2005;
280(48):
40112 - 40121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Hibbert and A. Rein
Preliminary Physical Mapping of RNA-RNA Linkages in the Genomic RNA of Moloney Murine Leukemia Virus
J. Virol.,
July 1, 2005;
79(13):
8142 - 8148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Buxton, G. Tachedjian, and J. Mak
Analysis of the Contribution of Reverse Transcriptase and Integrase Proteins to Retroviral RNA Dimer Conformation
J. Virol.,
May 15, 2005;
79(10):
6338 - 6348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Muriaux, S. Costes, K. Nagashima, J. Mirro, E. Cho, S. Lockett, and A. Rein
Role of Murine Leukemia Virus Nucleocapsid Protein in Virus Assembly
J. Virol.,
November 15, 2004;
78(22):
12378 - 12385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Hibbert, J. Mirro, and A. Rein
mRNA Molecules Containing Murine Leukemia Virus Packaging Signals Are Encapsidated as Dimers
J. Virol.,
October 15, 2004;
78(20):
10927 - 10938.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Andersen, S. A. Contera, B. Knudsen, C. K. Damgaard, F. Besenbacher, and J. Kjems
Role of the Trans-activation Response Element in Dimerization of HIV-1 RNA
J. Biol. Chem.,
May 21, 2004;
279(21):
22243 - 22249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cristofari, R. Ivanyi-Nagy, C. Gabus, S. Boulant, J.-P. Lavergne, F. Penin, and J.-L. Darlix
The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro
Nucleic Acids Res.,
May 11, 2004;
32(8):
2623 - 2631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-R. Mihailescu and J. P. Marino
A proton-coupled dynamic conformational switch in the HIV-1 dimerization initiation site kissing complex
PNAS,
February 3, 2004;
101(5):
1189 - 1194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Oshima, D. Muriaux, J. Mirro, K. Nagashima, K. Dryden, M. Yeager, and A. Rein
Effects of Blocking Individual Maturation Cleavages in Murine Leukemia Virus Gag
J. Virol.,
February 1, 2004;
78(3):
1411 - 1420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Windbichler, M. Werner, and R. Schroeder
Kissing complex-mediated dimerisation of HIV-1 RNA: coupling extended duplex formation to ribozyme cleavage
Nucleic Acids Res.,
November 15, 2003;
31(22):
6419 - 6427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Gubbins, D. C. Arthur, A. F. Ghetu, J. N. M. Glover, and L. S. Frost
Characterizing the Structural Features of RNA/RNA Interactions of the F-plasmid FinOP Fertility Inhibition System
J. Biol. Chem.,
July 18, 2003;
278(30):
27663 - 27671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ennifar, P. Walter, and P. Dumas
A crystallographic study of the binding of 13 metal ions to two related RNA duplexes
Nucleic Acids Res.,
May 15, 2003;
31(10):
2671 - 2682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Balakrishnan, B. P. Roques, P. J. Fay, and R. A. Bambara
Template Dimerization Promotes an Acceptor Invasion-Induced Transfer Mechanism during Human Immunodeficiency Virus Type 1 Minus-Strand Synthesis
J. Virol.,
April 15, 2003;
77(8):
4710 - 4721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Andersen, R. E. Jeeninga, C. K. Damgaard, B. Berkhout, and J. Kjems
Dimerization and Template Switching in the 5' Untranslated Region between Various Subtypes of Human Immunodeficiency Virus Type 1
J. Virol.,
March 1, 2003;
77(5):
3020 - 3030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ennifar, J.-C. Paillart, R. Marquet, B. Ehresmann, C. Ehresmann, P. Dumas, and P. Walter
HIV-1 RNA Dimerization Initiation Site Is Structurally Similar to the Ribosomal A Site and Binds Aminoglycoside Antibiotics
J. Biol. Chem.,
January 17, 2003;
278(4):
2723 - 2730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. G. Dirac, H. Huthoff, J. Kjems, and B. Berkhout
Requirements for RNA heterodimerization of the human immunodeficiency virus type 1 (HIV-1) and HIV-2 genomes
J. Gen. Virol.,
October 1, 2002;
83(10):
2533 - 2542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hoeprich and P. Guo
Computer Modeling of Three-dimensional Structure of DNA-packaging RNA (pRNA) Monomer, Dimer, and Hexamer of Phi29 DNA Packaging Motor
J. Biol. Chem.,
May 31, 2002;
277(23):
20794 - 20803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shehu-Xhilaga, M. Hill, J. A. Marshall, J. Kappes, S. M. Crowe, and J. Mak
The Conformation of the Mature Dimeric Human Immunodeficiency Virus Type 1 RNA Genome Requires Packaging of Pol Protein
J. Virol.,
March 27, 2002;
76(9):
4331 - 4340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ly and T. G. Parslow
Bipartite Signal for Genomic RNA Dimerization in Moloney Murine Leukemia Virus
J. Virol.,
March 7, 2002;
76(7):
3135 - 3144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shehu-Xhilaga, H. G. Kraeusslich, S. Pettit, R. Swanstrom, J. Y. Lee, J. A. Marshall, S. M. Crowe, and J. Mak
Proteolytic Processing of the P2/Nucleocapsid Cleavage Site Is Critical for Human Immunodeficiency Virus Type 1 RNA Dimer Maturation
J. Virol.,
October 1, 2001;
75(19):
9156 - 9164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-X. Feng, S. P. Moore, D. J. Garfinkel, and A. Rein
The Genomic RNA in Ty1 Virus-Like Particles Is Dimeric
J. Virol.,
November 15, 2000;
74(22):
10819 - 10821.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. J. Gorelick, W. Fu, T. D. Gagliardi, W. J. Bosche, A. Rein, L. E. Henderson, and L. O. Arthur
Characterization of the Block in Replication of Nucleocapsid Protein Zinc Finger Mutants from Moloney Murine Leukemia Virus
J. Virol.,
October 1, 1999;
73(10):
8185 - 8195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Ortiz-Conde and S. H. Hughes
Studies of the Genomic RNA of Leukosis Viruses: Implications for RNA Dimerization
J. Virol.,
September 1, 1999;
73(9):
7165 - 7174.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Jossinet, J. S. Lodmell, C. Ehresmann, B. Ehresmann, and R. Marquet
Identification of the in Vitro HIV-2/SIV RNA Dimerization Site Reveals Striking Differences with HIV-1
J. Biol. Chem.,
February 16, 2001;
276(8):
5598 - 5604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. G. Dirac, H. Huthoff, J. Kjems, and B. Berkhout
The Dimer Initiation Site Hairpin Mediates Dimerization of the Human Immunodeficiency Virus, Type 2 RNA Genome
J. Biol. Chem.,
August 17, 2001;
276(34):
32345 - 32352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-i. Takahashi, S. Baba, Y. Koyanagi, N. Yamamoto, H. Takaku, and G. Kawai
Two Basic Regions of NCp7 Are Sufficient for Conformational Conversion of HIV-1 Dimerization Initiation Site from Kissing-loop Dimer to Extended-duplex Dimer
J. Biol. Chem.,
August 10, 2001;
276(33):
31274 - 31278.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|